Evidence map›Paper›PMID 31791371›Full record

ArticleGenome biology2019

eIF4A2 drives repression of translation at initiation by Ccr4-Not through purine-rich motifs in the 5'UTR.

Ania Wilczynska, Sarah L Gillen, Tobias Schmidt, Hedda A Meijer, Rebekah Jukes-Jones, Claudia Langlais, Kari Kopra, Wei-Ting Lu, Jack D Godfrey, Benjamin R Hawley and 5 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Foxg1 and companions: Not only transcription factors.Neural regeneration research · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Dimeric Rocaglate Promotes Multivalent eIF4A-RNA Assembly.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Specialized ribosomes: integrating new insights and current challenges.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Ania WilczynskaCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. a.wilczynska@beatson.gla.ac.uk.
Sarah L GillenCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Tobias SchmidtCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Hedda A MeijerMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Rebekah Jukes-JonesMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Claudia LanglaisMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Kari KopraMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Wei-Ting LuMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Jack D GodfreyMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Benjamin R HawleyMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Kelly HodgeCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Sara ZanivanCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK.
Kelvin CainMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
John Le QuesneMRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.
Martin BushellCancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. m.bushell@beatson.gla.ac.uk.
MRC Toxicology Unit · GBCancer Research UK · GBCancer Research UK Scotland Institute · GBUniversity of Glasgow · GB

Funding

British Heart Foundation BB/M001865/1British Heart Foundation BB/N017005/1Cancer Research UK 24388Cancer Research UK 29252Cancer Research UK 29800Cancer Research UK A17196Cancer Research UK A29252Cancer Research UK C596/A17196Medical Research Council MC_EX_G0902052Medical Research Council MC_UP_1203/1Medical Research Council MC_UP_A600_1024Medical Research Council MC_UU_00025/6
6 · The paper itself

Abstract

backgroundRegulation of the mRNA life cycle is central to gene expression control and determination of cell fate. miRNAs represent a critical mRNA regulatory mechanism, but despite decades of research, their mode of action is still not fully understood.

resultsHere, we show that eIF4A2 is a major effector of the repressive miRNA pathway functioning via the Ccr4-Not complex. We demonstrate that while DDX6 interacts with Ccr4-Not, its effects in the mechanism are not as pronounced. Through its interaction with the Ccr4-Not complex, eIF4A2 represses mRNAs at translation initiation. We show evidence that native eIF4A2 has similar RNA selectivity to chemically inhibited eIF4A1. eIF4A2 exerts its repressive effect by binding purine-rich motifs which are enriched in the 5'UTR of target mRNAs directly upstream of the AUG start codon.

conclusionsOur data support a model whereby purine motifs towards the 3' end of the 5'UTR are associated with increased ribosome occupancy and possible uORF activation upon eIF4A2 binding.

Indexed as

Gene Expression Regulation5' Untranslated RegionsDEAD-box RNA HelicasesHumansMicroRNAsReceptors, CCR4Transcription Factors5' Untranslated RegionsCCR4 protein, humanCNOT1 protein, humanDEAD-box RNA HelicasesEIF4A2 protein, humanMicroRNAsReceptors, CCR4Transcription Factors

Identifiers

PMID31791371
PMCPMC6886185
OpenAlexW2993349905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.